![]() |
||||
Publikationer - Lungcancer |
||||
|
|
||||
|
|
||||
Utskriftsvänlig sida |
||||
Myrdal G, Lamberg K, Lambe M, Ståhle E, Wagenius G, Holmberg L. Regional diffe-rences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden). Lung Cancer. 2009 Jan; 63(1): 16-22.Wakelee HA, Chang ET, Gomez SL, Keegan THM, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW. Lung cancer incidence in never smokers. J Clin Oncol 2007; 25: 472-478.Wakelee HA, Chang ET, Gomez SL, Keegan THM, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW. Lung cancer incidence in never smokers. J Clin Oncol 2007; 25: 472-478.Sederholm C, Hillerdal G, Lamberg K, Kölbeck K, Dufmats M, Westberg R, Gawande SR. Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group, J Clin Oncol 2005 Nov 20; 23(33): 8380-8.Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon J-P, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-60.Johan Eriksson. Undersökning av tidstrender i registerdata. Lungcancerregistret ROC. U.U.D.M. Project Report 2004:3. Mars 2004. (Examensarbete i matematisk statistik, Matematiska institutionen, Uppsala Universitet). Läs examensarbetet här! |
||||
Uppdaterad 2009 03 24 av Jana Howe, webbansvarig